original ) (raw )Efficacy and safety of treatment with Incobotulinum toxin A (botulinum neurotoxin type A free from complexing proteins; NT 201) in post-stroke upper limb spasticity
Thomas Platz
Journal of Rehabilitation Medicine, 2011
View PDFchevron_right
Long-term safety of repeated high doses of incobotulinumtoxinA injections for the treatment of upper and lower limb spasticity after stroke
Nicola Smania
Journal of the neurological sciences, 2017
View PDFchevron_right
Botulinum toxin type A combined with neurodynamic mobilization for upper limb spasticity after stroke: a case report
Jorge Villafañe
Journal of chiropractic medicine, 2012
View PDFchevron_right
Safety Profile of High-Dose Botulinum Toxin Type A in Post-Stroke Spasticity Treatment
Stefano Carda
Clinical Drug Investigation, 2018
View PDFchevron_right
Botulinum toxin type A for upper limb spasticity following stroke: an open-label study with individualised, flexible injection regimens
jarosław sławek
Neurological Sciences, 2005
View PDFchevron_right
Safety and efficacy of incobotulinum toxin type A (NT 201-Xeomin) for the treatment of post-stroke lower limb spasticity: a prospective open-label study
Andrea Santamato , P. Fiore
European journal of physical and rehabilitation medicine, 2013
View PDFchevron_right
A literature review on the efficacy and safety of botulinum toxin: an injection in post-stroke spasticity
Mehri Salari
View PDFchevron_right
Dose-dependent response to intramuscular botulinum toxin type A for upper-limb spasticity in patients after a stroke
Catherine Turkel , Allison Brashear
Archives of Physical Medicine and Rehabilitation, 2004
View PDFchevron_right
Employment of higher doses of botulinum toxin type A to reduce spasticity after stroke
Andrea Santamato , Domenico Intiso
Journal of the Neurological Sciences, 2015
View PDFchevron_right
Botulinum toxin type A for the treatment of arm and hand spasticity in stroke patients
manuela crespo
Clinical Rehabilitation, 1997
View PDFchevron_right
Botulinum Toxin for the Upper Limb After Stroke (BoTULS) Trial
Mike Barnes
Stroke, 2011
View PDFchevron_right
A practical guide to optimizing the benefits of post-stroke spasticity interventions with botulinum toxin A: An international group consensus
Luis Jacinto
Journal of Rehabilitation Medicine, 2021
View PDFchevron_right
The early use of botulinum toxin in post-stroke spasticity: study protocol for a randomised controlled trial
Anand Pandyan
Trials, 2014
View PDFchevron_right
Early Botulinum Toxin Type A Injection for Post-Stroke Spasticity: A Longitudinal Cohort Study
cristina maria del prete
Toxins
View PDFchevron_right
Botulinum Toxin Type A for the Treatment of Lower Limb Spasticity after Stroke
Domenico Intiso
Drugs
View PDFchevron_right
Botulinum toxin type A for the treatment of the upper limb spasticity after stroke: a meta-analysis
Eduardo Cardoso
Arquivos De Neuro-psiquiatria, 2005
View PDFchevron_right
High doses of incobotulinumtoxinA for the treatment of post-stroke spasticity: are they safe and effective?
Madia LOZUPONE
Expert Opinion on Drug Metabolism & Toxicology, 2016
View PDFchevron_right
Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after stroke
Tan Hui Jan
The Medical journal of Malaysia, 2007
View PDFchevron_right
IncobotulinumtoxinA Efficacy and Safety in Adults with Upper-Limb Spasticity Following Stroke: Results from the Open-Label Extension Period of a Phase 3 Study
Atul Patel
Advances in Therapy
View PDFchevron_right
Pooled Analysis of the Safety of Botulinum Toxin Type A in the Treatment of Poststroke Spasticity
Catherine Turkel
Archives of Physical Medicine and Rehabilitation, 2006
View PDFchevron_right
Efficacy of physical therapy associated with botulinum toxin type A on functional performance in post-stroke spasticity: A randomized, double-blinded, placebo-controlled trial
Marilia Lira
Neurology international, 2018
View PDFchevron_right
IN16-MO-04 Potential role of Botulinum Toxin-A as early intervention in post stroke spasticity
Raymond L Rosales
Journal of the Neurological Sciences, 2009
View PDFchevron_right
Botulinum toxin type A in post-stroke lower limb spasticity: a multicenter, double-blind, placebo-controlled trial
Ryuji Kaji
Journal of Neurology, 2010
View PDFchevron_right
Sustained Efficacy of Incobotulinumtoxina Following Repeated Injections for Upper-Limb Post-Stroke Spasticity: A Post Hoc Analysis
Reinhard Hiersemenzel
2021
View PDFchevron_right
Repeated Treatments With Botulinum Toxin Type A Produce Sustained Decreases in the Limitations Associated With Focal Upper-Limb Poststroke Spasticity for Caregivers and Patients
Scott Millis
Archives of Physical Medicine and Rehabilitation, 2008
View PDFchevron_right
“Appropriate Treatment” and Therapeutic Window in Spasticity Treatment with IncobotulinumtoxinA: From 100 to 1000 Units
Marisa Megna
Toxins, 2018
View PDFchevron_right
High Dosage of Botulinum Toxin Type A in Adult Subjects with Spasticity Following Acquired Central Nervous System Damage: Where Are We at?
Domenico Intiso
Toxins
View PDFchevron_right
Intensive therapy after botulinum toxin in adults with spasticity after stroke versus botulinum toxin alone or therapy alone: a pilot, feasibility randomized trial
Natasha Lannin
Pilot and Feasibility Studies
View PDFchevron_right